<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343276</url>
  </required_header>
  <id_info>
    <org_study_id>ICSC-2015</org_study_id>
    <nct_id>NCT02343276</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs</brief_title>
  <official_title>Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Cardiologia de Santa Catarina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Cardiologia de Santa Catarina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center study, randomized, double-blind, placebo controlled, with patients undergoing
      diagnostic or therapeutic catheterization via the transradial approach. Patients will be
      randomized into two groups: one group will receive the vasodilator nitroglycerin during the
      procedure (intervention group), and a second group will receive saline 0.9% in the same
      volume and time during the procedure (control group).

      Will be evaluated: incidence of spasms of the radial artery, ability to perform the procedure
      without the need to change the access site, pain presented by the patient, time and total
      radiation of the procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Assessment Using Visual Analogue Scale</measure>
    <time_frame>Five minutes after sheath removal</time_frame>
    <description>the patients' feeling of pain in the forearm, and it was measured using a visual analogue scale (VAS), applied at the end of the procedure by an interventional nurse. The VAS consists of a single line measuring 100 mm, anchored by verbal descriptors, saying 'no pain' and 'worst possible pain'. Higher values mean a worse pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Duration</measure>
    <time_frame>Immediate</time_frame>
    <description>Procedure duration, from artery catheterization up to removal of sheath.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation Exposure</measure>
    <time_frame>Immediate</time_frame>
    <description>Total radiation required to complete the procedure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">328</enrollment>
  <condition>Cardiac Catheterisation</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin</intervention_name>
    <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Tridil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for cardiac catheterization

          -  Suitable candidates for transradial approach

        Exclusion Criteria:

          -  AMI

          -  Intubated patients

          -  Complications during procedure (cardiac arrest, pulmonary edema, cardiogenic shock,
             stroke)

          -  Prior inclusion in this trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto L da Silva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Cardiologia de Santa Catarina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto de Cardiologia de Santa Catarina</name>
      <address>
        <city>São Jose</city>
        <state>SC</state>
        <zip>88000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 15, 2015</study_first_submitted>
  <study_first_submitted_qc>January 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2015</study_first_posted>
  <results_first_submitted>September 28, 2018</results_first_submitted>
  <results_first_submitted_qc>February 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 31, 2019</results_first_posted>
  <last_update_submitted>February 14, 2019</last_update_submitted>
  <last_update_submitted_qc>February 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Cardiologia de Santa Catarina</investigator_affiliation>
    <investigator_full_name>Roberto Léo da Silva</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Radial Spasm</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study was designed as a single-centre, prospective, randomised, placebo-controlled, double-blind trial with an all-comers design. All eligible patients were aged 18 years or over with a clinical indication for coronary angiography (ad hoc angioplasty was allowed) or percutaneous coronary intervention (PCI).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
        </group>
        <group group_id="P2">
          <title>Intervention</title>
          <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="164"/>
                <participants group_id="P2" count="164"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="164"/>
                <participants group_id="P2" count="164"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
        </group>
        <group group_id="B2">
          <title>Intervention</title>
          <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="164"/>
            <count group_id="B2" value="164"/>
            <count group_id="B3" value="328"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.79" spread="11.15"/>
                    <measurement group_id="B2" value="60.93" spread="11.90"/>
                    <measurement group_id="B3" value="60.36" spread="11.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="164"/>
                    <measurement group_id="B3" value="328"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>METERS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.65" spread="0.09"/>
                    <measurement group_id="B2" value="1.64" spread="0.09"/>
                    <measurement group_id="B3" value="1.65" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>KILOGRAMS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.61" spread="28.13"/>
                    <measurement group_id="B2" value="76.59" spread="28.47"/>
                    <measurement group_id="B3" value="76.6" spread="28.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.13" spread="7.33"/>
                    <measurement group_id="B2" value="28.47" spread="7.45"/>
                    <measurement group_id="B3" value="28.32" spread="7.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Assessment Using Visual Analogue Scale</title>
        <description>the patients' feeling of pain in the forearm, and it was measured using a visual analogue scale (VAS), applied at the end of the procedure by an interventional nurse. The VAS consists of a single line measuring 100 mm, anchored by verbal descriptors, saying 'no pain' and 'worst possible pain'. Higher values mean a worse pain.</description>
        <time_frame>Five minutes after sheath removal</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
          </group>
          <group group_id="O2">
            <title>Intervention</title>
            <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Assessment Using Visual Analogue Scale</title>
          <description>the patients' feeling of pain in the forearm, and it was measured using a visual analogue scale (VAS), applied at the end of the procedure by an interventional nurse. The VAS consists of a single line measuring 100 mm, anchored by verbal descriptors, saying 'no pain' and 'worst possible pain'. Higher values mean a worse pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.75" spread="23.1"/>
                    <measurement group_id="O2" value="24.74" spread="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Duration</title>
        <description>Procedure duration, from artery catheterization up to removal of sheath.</description>
        <time_frame>Immediate</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
          </group>
          <group group_id="O2">
            <title>Intervention</title>
            <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Duration</title>
          <description>Procedure duration, from artery catheterization up to removal of sheath.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.24" spread="12.31"/>
                    <measurement group_id="O2" value="21.36" spread="13.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiation Exposure</title>
        <description>Total radiation required to complete the procedure.</description>
        <time_frame>Immediate</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
          </group>
          <group group_id="O2">
            <title>Intervention</title>
            <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
          </group>
        </group_list>
        <measure>
          <title>Radiation Exposure</title>
          <description>Total radiation required to complete the procedure.</description>
          <units>mGy</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="660.92" spread="433.25"/>
                    <measurement group_id="O2" value="655.61" spread="441.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo (saline solution 10 ml) in radial artery after sheath insertion
Placebo: Placebo (saline solution 10 ml) in radial artery after sheath insertion</description>
        </group>
        <group group_id="E2">
          <title>Intervention</title>
          <description>Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion
Nitroglycerin: Nitroglycerin (200 micrograms) + saline solution 10 ml in radial artery after sheath insertion</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="164"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="164"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="164"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="164"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Procedures were conducted in a single, high-volume center. All, but one, operators had high experience in radial access.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Roberto Léo da Silva</name_or_title>
      <organization>Instituto de Cardiologia de Santa Catarina</organization>
      <phone>55 48 32719077</phone>
      <email>robertoleo@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

